Position in AVIR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$423,726
-$55,384 QoQ
Shares Held
91,124
+2.3% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 124 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. AVIR ranks #198 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $423,726 | 91,124 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $479,110 | 89,054 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $335,494 | 93,976 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $329,474 | 113,612 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $429,912 | 119,420 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $348,164 | 116,443 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $434,816 | 129,796 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $445,931 | 133,114 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $455,449 | 137,598 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $573,284 | 141,902 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $448,703 | 147,116 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $402,924 | 134,308 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $527,545 | 141,055 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $414,351 | 123,687 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $568,027 | 118,093 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $660,688 | 116,114 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $778,955 | 109,712 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $593,751 | 82,237 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $770,976 | 86,239 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,004,361 | 85,692 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,763,422 | 82,096 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,059,815 | 17,163 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $522,918 | 12,516 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||